Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Hartmann, S; Botha, SM; Gray, CM; Valdes, DS; Tong, SP; Kaituu-Lino, TJ; Herse, F; Bergman, L; Cluver, CA; Dechend, R; Nonn, O.
Can single-cell and spatial omics unravel the pathophysiology of pre-eclampsia?
J REPROD IMMUNOL. 2023; 159: 104136
Doi: 10.1016/j.jri.2023.104136
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Nonn Olivia
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Pre-eclampsia is a leading cause of maternal and fetal morbidity and mortality. Characterised by the onset of hypertension and proteinuria in the second half of pregnancy, it can lead to maternal end-organ injury such as cerebral ischemia and oedema, pulmonary oedema and renal failure, and potentially fatal outcomes for both mother and fetus. The causes of the different maternal end-organ phenotypes of pre-eclampsia and why some women develop pre-eclampsia condition early in pregnancy have yet to be elucidated. Omics methods include proteomics, genomics, metabolomics, transcriptomics. These omics techniques, previously mostly used on bulk tissue and individually, are increasingly available at a single cellular level and can be combined with each other. Multi-omics techniques on a single-cell or spatial level provide us with a powerful tool to understand the pathophysiology of pre-eclampsia. This review will explore the status of omics methods and how they can and could contribute to understanding the pathophysiology of pre-eclampsia.
- Find related publications in this database (Keywords)
- Pre-eclampsia
- Single-cell RNA-seq
- Multi-omics
- Spatial omics
- Placenta